Page last updated: 2024-08-23

paclitaxel and Huntington Disease

paclitaxel has been researched along with Huntington Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Badger, JD; Bortolon, R; Dyer, RB; Estévez, A; Heldebrant, MP; Kovtun, IV; McMurray, CT; Perez-Terzic, CM; Terzic, A; Trushina, E; Windebank, AJ; Yao, J1
Goto, J; Hazeki, N; Kanazawa, I; Nakamura, K1

Other Studies

2 other study(ies) available for paclitaxel and Huntington Disease

ArticleYear
Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease.
    Proceedings of the National Academy of Sciences of the United States of America, 2003, Oct-14, Volume: 100, Issue:21

    Topics: Active Transport, Cell Nucleus; Cell Death; Cell Nucleus; Cell Survival; Cells, Cultured; Cytoplasm; Humans; Huntingtin Protein; Huntington Disease; Microtubules; Mutation; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Paclitaxel

2003
Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract.
    Biochemical and biophysical research communications, 1999, Mar-16, Volume: 256, Issue:2

    Topics: Animals; Blotting, Western; Cell Nucleus; COS Cells; Cycloheximide; Cytochalasin D; Cytoplasm; Exons; Humans; Huntingtin Protein; Huntington Disease; Molecular Weight; Nerve Tissue Proteins; Nocodazole; Nuclear Proteins; Paclitaxel; Peptide Fragments; Peptides; Protein Binding; Recombinant Fusion Proteins; Time Factors; Transfection; Tunicamycin

1999